QP64-25 Commercial Pharmacy Benefit Exclusion for Enflonsia™, Imuldosa™, Osenvelt®, Stoboclo®, Yeztugo® and Zusduri™

QP63-25 MHCP Pharmacy Benefit Exclusion for Enflonsia™, Lynozyfic™ and Zusduri™

QP61-25 Change in Replacement Claim Processing

QP45R1-25 Multiple Medicaid Coverages Listed on the Same Claim

QP69-25 Update on PAC Authorization Submission Process, Effective August 1, 2025

QP68-25 MHCP Process for Behavioral Health Residential Prior Authorization (PA) Submission

Cervical cancer screening voucher - Spanish

Examen De Detección De Cáncer De Cuello Uterino (De 21 A Los 64 Años)

Cervical cancer screening voucher

Cervical cancer screening voucher - Hmong

Qho Kev Kuaj Tshuaj Xyuas Tus Mob Khees Xaws Rau Lub Ncauj Tsev Me Nyuam (Hnub Nyoog 21 Txog 64 Xyoos)

Cervical cancer screening voucher - Karen